Reich Kristian sold MLTX
February 28, 2024 · Form 4 insider transaction
Reich Kristian sold 31,910 shares of MoonLake Immunotherapeutics at $55.00 per share, a transaction worth $1.76M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on October 16, 2023.; Represents the ordinary shares of the Issuer owned by JeruCON Beratungsgesellschaft mbH. Dr. Reich directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the ordinary shares owned by JeruCON Beratungsgesellschaft mbH.